SaltX Technology Holding B Logo

SaltX Technology Holding B

Develops electric calcination tech to decarbonize heavy industries like cement and capture CO2.

SALT | ST

Overview

Corporate Details

ISIN(s):
SE0005308541 (+1 more)
LEI:
549300W31010S0FY9U64
Country:
Sweden
Address:
Västertorpsvägen 135, 129 44 Hägersten
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

SaltX Technology is a greentech company dedicated to decarbonizing heavy industries and eliminating their dependency on fossil fuels. The company innovates and industrializes electrification and carbon separation technologies targeting hard-to-abate sectors like cement and quicklime. Its core technology is the Electric Arc Calciner (EAC), a proprietary electric calcination process that replaces fossil-fuel heating. The EAC technology simultaneously separates and captures process-related CO2 emissions, creating a pathway to zero-emission manufacturing. SaltX collaborates with major industrial partners, such as Holcim and SMA Mineral, to scale its solutions and achieve gigaton-level impact on global emissions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SaltX Technology Holding B filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SaltX Technology Holding B

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SaltX Technology Holding B via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Isofol Medical Logo
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden
ISOFOL
IVIM Technology, Inc. Logo
Provides intravital microscopy systems & CRO services for preclinical research and drug discovery.
South Korea
460470
IXICO PLC Logo
AI-powered neuroimaging and biomarker analytics for neurological clinical trials.
United Kingdom
IXI
Jade Biosciences, Inc. Logo
Clinical-stage biotech developing therapies for autoimmune and inflammatory diseases.
United States of America
JBIO
Jasper Therapeutics, Inc. Logo
Develops mast cell-depleting antibody therapies for chronic diseases and stem cell transplants.
United States of America
JSPR
J. Molner AS Logo
A CDRO specializing in generic injectable and topical drugs for the North American market.
Estonia
JML
Kadimastem Ltd. Logo
Develops off-the-shelf stem cell therapies for diabetes & neurodegenerative diseases.
Israel
KDST
KAINOS MEDICINE, INC. Logo
Develops small molecule drugs for neurodegenerative diseases, cancers, and infectious diseases.
South Korea
284620
Kairos Pharma, LTD. Logo
Develops novel oncology therapies to reverse drug resistance and immune suppression.
United States of America
KAPA
Kancera Logo
Develops small molecule drugs targeting the fractalkine axis for cancer and inflammatory diseases.
Sweden
KAN

Talk to a Data Expert

Have a question? We'll get back to you promptly.